Activation of LDL receptor gene expression in HepG2 cells by hepatocyte growth factor

被引:0
|
作者
Pak, YK
Kanuck, MP
Berrios, D
Briggs, MR
Cooper, AD
Ellsworth, JL
机构
[1] PALO ALTO MED FDN,RES INST,PALO ALTO,CA 94301
[2] STANFORD UNIV,SCH MED,DEPT MED,STANFORD,CA 94305
[3] LIGAND PHARMACEUT INC,SAN DIEGO,CA 92121
关键词
growth factors; gene transcription; liver regeneration;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The effect of recombinant human hepatocyte growth factor (HGF) on low density lipoprotein (LDL) receptor gene expression was studied in the human hepatoma cell line HepG2. HepG2 cells were incubated with serum-free media in the presence and absence of HGF for various times and I-125-labeled LDL specific binding at 4 degrees C, uptake at 37 degrees C, and the levels of LDL receptor mRNA were measured. Incubation with HGF produced time- and concentration-dependent increases in I-125-labeled LDL binding (2-fold), uptake (2.5-fold), and LDL receptor mRNA (6-fold). HGF increased the rate of LDL receptor gene transcription 4- to 5-fold relative to that of several ''house keeping'' genes as measured by nuclear run-on transcription. The half-life of LDL receptor mRNA, measured with actinomycin D, was not increased in HGF-treated cells. The stimulation of LDL receptor expression occurred independently of changes in cellular cholesterol or DNA biosynthesis or total cell protein. HepG2 cells were transiently transfected with plasmids bearing either three copies of repeats 2 and 3 (pLDLR(23)(3)LUC) or one copy of the LDL receptor promoter from -556 to +53 (pLDLR600LUC) linked to firefly luciferase. Incubation of pLDLR(23)(3)LUC- or pLDLR600LUC-transfected cells with HGF for 4 or 24 h at 37 degrees C produced a concentration-dependent increase in luciferase activity. A maximal stimulation of 3-to 6-fold was achieved for each construct at an HGF concentration of 100 ng/ml. In contrast, HGF had little or no effect on reporter activity in HepG2 cells transfected with a luciferase reporter plasmid bearing the HMG-CoA reductase promoter extending from -325 to +22. Thus, when compared to the native LDL receptor promoter, multiple copies of repeats 2 and 3 of the LDL receptor promoter can fully support activation of the luciferase reporter gene by HGF, demonstrating that the effect of HGF is mediated through the SRE-1. The lack of HGF effects mediated through the HMG-CoA reductase sterol regulatory element suggests, however, that sterol depletion may not be responsible for the induction of the LDL receptor promoter by growth factors. The signalling pathways or effecters responsible for activation of the LDL receptor and HMG-Coa reductase genes thus differ in their response to HGF. These data suggest that the level of SREBP's reaching the nucleus may be determined by as yet unidentified second messengers as well as by sterols.-Pak, Y. K., M. P. Kanuck, D, Berries, M. R. Briggs, A. D. Cooper, and J. L. Ellsworth. Activation of LDL receptor gene expression in HepG2 cells by hepatocyte growth factor.
引用
收藏
页码:985 / 998
页数:14
相关论文
共 50 条
  • [31] Effect of hepatocyte growth factor on methionine adenosyltransferase genes and growth is cell density-dependent in HepG2 cells
    Yang, Heping
    Magilnick, Nathaniel
    Noureddin, Mazen
    Mato, Jose M.
    Lu, Shelly C.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2007, 210 (03) : 766 - 773
  • [32] Hepatocyte Growth Factor Enhances Antineoplastic Effect of 5-Fluorouracil by Increasing UPP1 Expression in HepG2 Cells
    Okumura, Manabu
    Iwakiri, Tomomi
    Yoshikawa, Naoki
    Nagatomo, Takao
    Ayabe, Takanori
    Tsuneyoshi, Isao
    Ikeda, Ryuji
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (16)
  • [33] Forced expression of RDH10 gene retards growth of HepG2 cells
    Rossi, Elena
    Picozzi, Paola
    Bodega, Beatrice
    Lavazza, Cistiana
    Carlo-Stella, Carmelo
    Marozzi, Anna
    Ginelli, Enrico
    CANCER BIOLOGY & THERAPY, 2007, 6 (02) : 238 - 245
  • [34] Regulation of fibrinogen gene expression in HepG2 cells by sterols
    Xia, H
    Redman, CM
    MOLECULAR BIOLOGY OF THE CELL, 2000, 11 : 162A - 162A
  • [35] Hepatocyte growth factor suppresses the anticancer effect of irinotecan by decreasing the level of active metabolite in HepG2 cells
    Okumura, Manabu
    Iwakiri, Tomomi
    Takagi, Akinori
    Hirabara, Yasutoshi
    Kawano, Yohei
    Arimori, Kazuhiko
    BIOCHEMICAL PHARMACOLOGY, 2011, 82 (11) : 1720 - 1730
  • [36] Regulation of phospholipase A2 gene expression by tumour necrosis factor α in human HepG2 cells
    Makkinje, M
    Bao, YP
    Ridley, S
    Williamson, G
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1997, 25 (04) : S558 - S558
  • [37] COORDINATE REGULATION OF SQUALENE SYNTHASE, HMGCOA REDUCTASE AND LDL RECEPTOR IN HEPG2 CELLS
    CHARLES, AD
    BUCKETT, LK
    MCTAGGART, F
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 266 - 266
  • [38] HCV core protein activates expression of vascular endothelial growth factor in HepG2 cells
    刘重阳
    刘为纹
    杨建民
    房殿春
    中华肝脏病杂志, 2001, (04) : 214 - 216
  • [39] Curcumin Up-Regulates LDL Receptor Expression via the Sterol Regulatory Element Pathway in HepG2 Cells
    Dou, Xiaobing
    Fan, Chunlei
    Wo, Like
    Yan, Jin
    Qian, Ying
    Wo, Xingde
    PLANTA MEDICA, 2008, 74 (11) : 1374 - 1379
  • [40] Long-chain polyunsaturated fatty acids upregulate LDL receptor protein expression in fibroblasts and HepG2 cells
    Yu-Poth, S
    Yin, DZ
    Kris-Etherton, PM
    Zhao, GX
    Etherton, TD
    JOURNAL OF NUTRITION, 2005, 135 (11): : 2541 - 2545